An Open-Label Uncontrolled Study of the Safety and Efficacy of Ambrisentan in Participants With Exercise-Induced Pulmonary Arterial Hypertension (PAH)
Clinical trial NCT01338636 · COMPLETED
Trial details
- NCT number
- NCT01338636
- Sponsor
- Brigham and Women's Hospital
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2008-09-01
- Primary completion
- 2016-02-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.